Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
Preoperative skeletal muscle loss was reported to be associated with a postoperative poor prognosis in non-small cell lung cancer (NSCLC) patients. The aim of this study was to elucidate the relationship between the change in skeletal muscle mass following surgery and the postoperative outcomes in NSCLC patients. The data analyzed 204 NSCLC patients who had undergone curative lung resection and whose preoperative and postoperative (1 year) computed tomography images were available. The skeletal muscle area (SMA) at the 12th thoracic vertebra level was used. Post/pre ratio was defined as postoperative normalized SMA (cm2/m2) divided by preoperative normalized SMA. The cut-off value was set to post/pre ratio = 0.9. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, modified Glasgow prognostic score, and prognostic nutritional index were used to estimate change in the nutritional status. Seventy patients (34.3%) were classified into the SMA-decreased group. Low body mass index was significantly associated with the SMA-decreased patients (p = 0.019). The SMA-decreased status was found to be an independent prognostic factor for overall survival and disease-free survival (p < 0.001 and p = 0.001, respectively). The SMA-decreased status was significantly associated with the postoperative exacerbation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, modified Glasgow prognostic score, and prognostic nutritional index (p = 0.009, p = 0.026, p = 0.003, and p = 0.013, respectively). Skeletal muscle loss after surgery is significantly associated with poor postoperative outcomes in NSCLC patients. Further studies are needed for investigating the clinical impact of postoperative nutritional intervention.